Comments
Lupin has received tentative approval from the US health regulator to sell Olmesartan medoximil tablets, used for treating high blood pressure, in the American market.
“It has received tentative approval for Olmesartan medoximil tablets, 5 mg, 20 mg and 40 mg from the US Food and Drug Administration (USFDA),” Lupin Ltd said in a BSE filing today.
Olmesartan medoximil tablets, generic version of Daiichi Sankyo’s Benicar, are indicated for the treatment of hypertension, along with other antihypertensive agents to lower blood pressure, it added.
Quoting IMS MAT September 2016 sales data, Lupin further said that Benicar tablets had annual US sales of $1.06 billion.
The company shares were trading down by 0.09 per cent at Rs 1,444 on the BSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.